Int J Pharm. 2009 Oct 1;380(1-2):1-15. Epub 2009 Aug 3.

Levodopa delivery systems for the treatment of Parkinson's disease: an overview.

Source

Université Libre de Bruxelles, Brussels, Belgium. jonathan.goole@ulb.ac.be

Abstract

This review describes the different drug delivery systems containing levodopa that are used in the treatment of Parkinson's disease. Their composition, process of preparation, advantages, disadvantages and limitations are discussed as well as the major objective in the management of Parkinson's disease according to the pathology of the disease.

PMID:: 19651197; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Parkinson's Disease - MedlinePlus Health Information

Molecular Biology Databases

LEVODOPA - HSDB

Supplemental Content

Save items

Related citations in PubMed

Review Levodopa delivery systems: advancements in delivery of the gold standard. [Expert Opin Drug Deliv. 2010]
Review Levodopa delivery systems: advancements in delivery of the gold standard.
Ngwuluka N, Pillay V, Du Toit LC, Ndesendo V, Choonara Y, Modi G, Naidoo D. Expert Opin Drug Deliv. 2010 Feb; 7(2):203-24.
Review Potential nondopaminergic drugs for Parkinson's disease. [Adv Neurol. 2003]
Review Potential nondopaminergic drugs for Parkinson's disease.
Silverdale MA, Fox SH, Crossman AR, Brotchie JM. Adv Neurol. 2003; 91:273-91.
Review New non-oral drug delivery systems for Parkinson's disease treatment. [Expert Opin Drug Deliv. 2011]
Review New non-oral drug delivery systems for Parkinson's disease treatment.
Md S, Haque S, Sahni JK, Baboota S, Ali J. Expert Opin Drug Deliv. 2011 Mar; 8(3):359-74. Epub 2011 Feb 12.
Review Levodopa therapeutics for Parkinson's disease: new developments. [Parkinsonism Relat Disord. 2009]
Review Levodopa therapeutics for Parkinson's disease: new developments.
LeWitt PA. Parkinsonism Relat Disord. 2009 Jan; 15 Suppl 1:S31-4.
Review Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapy. [Prog Brain Res. 2008]
Review Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapy.
Fox SH, Chuang R, Brotchie JM. Prog Brain Res. 2008; 172:479-94.

See reviews... See all...

Cited by 1 PubMed Central article

The first global screening of protein substrates bearing protein-bound 3,4-Dihydroxyphenylalanine in Escherichia coli and human mitochondria. [J Proteome Res. 2010]
The first global screening of protein substrates bearing protein-bound 3,4-Dihydroxyphenylalanine in Escherichia coli and human mitochondria.
Lee S, Chen Y, Luo H, Wu AA, Wilde M, Schumacker PT, Zhao Y. J Proteome Res. 2010 Nov 5; 9(11):5705-14. Epub 2010 Oct 12.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Levodopa delivery systems for the treatment of Parkinson's disease: an overview.
Levodopa delivery systems for the treatment of Parkinson's disease: an overview.
Int J Pharm. 2009 Oct 1 ;380(1-2):1-15. Epub 2009 Aug 3 .

PubMed
Quantifying perivascular sympathetic innervation: regional differences in male C...
Quantifying perivascular sympathetic innervation: regional differences in male C57BL/6 mice at 3 and 20 months.
J Neurosci Methods. 2009 Oct 30 ;184(1):124-8. Epub 2009 Aug 3 .

PubMed
First evidence of "paralytic shellfish toxins" and cylindrospermopsin in a Mexic...
First evidence of "paralytic shellfish toxins" and cylindrospermopsin in a Mexican freshwater system, Lago Catemaco, and apparent bioaccumulation of the toxins in "tegogolo" snails (Pomacea patula catemacensis).
Toxicon. 2010 May ;55(5):930-8. Epub 2009 Aug 3 .

PubMed
Structural and functional diversity of novel coronin 1C (CRN2) isoforms in muscl...
Structural and functional diversity of novel coronin 1C (CRN2) isoforms in muscle.
J Mol Biol. 2009 Oct 23 ;393(2):287-99. Epub 2009 Aug 3 .

PubMed
Fatherhood, pairbonding and testosterone in the Philippines.
Fatherhood, pairbonding and testosterone in the Philippines.
Horm Behav. 2009 Oct ;56(4):429-35. Epub 2009 Aug 3 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: